Edition:
United Kingdom

Intec Pharma Ltd (NTEC.OQ)

NTEC.OQ on NASDAQ Stock Exchange Capital Market

4.95USD
15 Dec 2017
Change (% chg)

$-0.35 (-6.60%)
Prev Close
$5.30
Open
$5.30
Day's High
$5.30
Day's Low
$4.95
Volume
41,596
Avg. Vol
24,484
52-wk High
$9.80
52-wk Low
$4.20

Chart for

About

Intec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodyna... (more)

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 88.66 16.44
EPS (TTM): -- -- --
ROI: -- 2.36 10.62
ROE: -- 2.96 14.20

BRIEF-Intec Pharma reports Q3 earnings per share $0.40

* Intec Pharma reports third quarter 2017 operating and financial results

15 Nov 2017

BRIEF-Acuta Capital Partners reports 10.5 pct passive stake in Intec Pharma

* Acuta Capital Partners reports 10.5 pct passive stake in Intec Pharma Ltd as of Aug 31 - SEC filing Source text: (http://bit.ly/2gRgBs0) Further company coverage:

08 Sep 2017

BRIEF-Adage Capital Partners reports 6.64 pct passive stake in Intec Pharma

* Adage Capital Partners GP LLC reports 6.64 percent passive stake in Intec Pharma Ltd ‍​as of August 16 - sec filing Source text : http://bit.ly/2vvPmop Further company coverage:

25 Aug 2017

BRIEF-Intec Pharma announces pricing of $50 mln public offering of ordinary shares

* Intec Pharma announces pricing of $50.0 million public offering of ordinary shares

16 Aug 2017

BRIEF-Intec Pharma announces proposed public offering of ordinary shares

* Intec Pharma announces proposed public offering of ordinary shares

15 Aug 2017

BRIEF-Intec Pharma reports financial results for the first half of 2017​

* Intec Pharma reports financial results for the first six months of 2017

09 Aug 2017

BRIEF-Intec Pharma reports clinical results from phase I trial of accordion pill for cannabinoid therapies

* Intec Pharma reports clinical results from phase i trial of accordion pill for cannabinoid therapies

03 Aug 2017

BRIEF-Intec Pharma granted patent in Hong Kong for Accordion pill

* Intec Pharma Ltd says granted patent in Hong Kong for Accordion pill

19 Jul 2017

BRIEF-Intec Pharma Ltd appoints U.S. Life sciences executive and vice chairman Jeffrey Meckler as CEO

* Intec Pharma Ltd - Intec Pharma appoints U.S. Life sciences executive and vice chairman Jeffrey Meckler as chief executive officer‍​

10 Jul 2017

BRIEF-Intec Pharma appoints Jeffrey Meckler as CEO

* Intec Pharma appoints U.S. Life Sciences executive and vice chairman Jeffrey A. Meckler as chief executive officer

10 Jul 2017

Earnings vs. Estimates